Identification of STAT3 as a specific substrate of breast tumor kinase

Oncogene

Volumn 25, Issue 35, 2006, Pages 4904-4912

  Liu, L ^a   Gao, Y ^a   Qiu, H ^b   Miller, W T ^b   Poli, V ^c   Reich, N C ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

Signal transduction; Transcription factor; Tyrosine phosphorylation

Indexed keywords

BREAST TUMOR KINASE; ENZYME; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CATALYSIS; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REPRESSION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; HELA CELLS; HUMANS; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; STAT3 TRANSCRIPTION FACTOR; SUBSTRATE SPECIFICITY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TYROSINE;

EID: 33746897689     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209501     Document Type: Article

References (55)

1. Akira S. (1999). Stem Cell 17: 138-146.
2. Banninger G, Reich NC. (2004). J Biol Chem 279: 39199-39206.
3. Barker KT, Jackson LE, Crompton MR. (1997). Oncogene 15: 799-805.
4. Benekli M, Baer MR, Baumann H, Wetzler M. (2003). Blood 101: 2940-2954.
5. Bowman T, Garcia R, Turkson J, Jove R. (2000). Oncogene 19: 2474-2488.
6. Bromberg J. (2002). J Clin Invest 109: 1139-1142.
7. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C et al. (1999). Cell 98: 295-303.
8. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. (2004). Mol Cell Biol 24: 10558-10572.
9. Chiarle R, Simmons WJ, Cai H, Dhall G, Zamo A, Raz R et al. (2005). Nat Med 11: 623-629.
10. Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML et al. (2003). Oncogene 22: 4102-4110.
11. Coyle JH, Guzik BW, Bor YC, Jin L, Eisner-Smerage L, Taylor SJ et al. (2003). Mol Cell Biol 23: 92-103.
12. Darnell Jr JE. (1997). Science 277: 1630-1635.
13. Darnell Jr JE, Kerr IM, Stark GR. (1994). Science 264: 1415-1421.
14. Decker T. (1999). Cell Mol Life Sci 55: 1505-1508.
15. Derry JJ, Prins GS, Ray V, Tyner AL. (2003). Oncogene 22: 4212-4220.
16. Derry JJ, Richard S, Valderrama Carvajal H, Ye X, Vasioukhin V, Cochrane AW et al. (2000). Mol Cell Biol 20: 6114-6126.
17. Easty DJ, Mitchell PJ, Patel K, Florenes VA, Spritz RA, Bennett DC. (1997). Int J Cancer 71: 1061-1065.
18. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K et al. (1997). Nature 387: 921-924.
19. Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC. (2001). Proc Natl Acad Sci USA 98: 9014-9019.
20. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA et al. (2001). Oncogene 20: 2499-2513.
21. Haegebarth A, Heap D, Bie W, Derry JJ, Richard S, Tyner AL. (2004). J Biol Chem 279: 54398-54404.
22. Harvey AJ, Crompton MR. (2003). Oncogene 22: 5006-5010.
23. Hennipman A, van Oirschot BA, Smits J, Rijksen G, Staal GE. (1989). Cancer Res 49: 516-521.
24. Ihle JN. (2001). Curr Opin Cell Biol 13: 211-217.
25. Kamalati T, Jolin HE, Fry MJ, Crompton MR. (2000). Oncogene 19: 5471-5476.
26. Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ et al. (1996). J Biol Chem 271: 30956-30963.
27. Kang KN, Kim M, Pae KM, Lee ST. (2002). Biochim Biophys Acta 1574: 365-369.
28. Kim H, Lee ST. (2005). J Biol Chem 280: 28973-28980.
29. Krebs DL, Hilton DJ. (2000). J Cell Sci 113(Part 16): 2813-2819.
30. Lacronique V, Boureux A, Monni R, Dumon S, Mauchauffe M, Mayeux P et al. (2000). Blood 95: 2076-2083.
31. Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC et al. (2003). Proc Natl Acad Sci USA 100: 4138-4143.
32. Levy DE, Darnell Jr JE. (2002). Nat Rev Mol Cell Biol 3: 651-662.
33. Liu L, McBride KM, Reich NC. (2005). Proc Natl Acad Sci USA 102: 8150-8155.
34. Llor X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J et al. (1999). Clin Cancer Res 5: 1767-1777.
35. McBride KM, McDonald C, Reich NC. (2000). EMBO J 19: 6196-6206.
36. Minoguchi M, Minoguchi S, Aki D, Joo A, Yamamoto T, Yumioka T et al. (2003). J Biol Chem 278: 11182-11189.
37. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ et al. (1994). Oncogene 9: 2383-2390.
38. Mitchell PJ, Barker KT, Shipley J, Crompton MR. (1997). Oncogene 15: 1497-1502.
39. Mitchell PJ, Sara EA, Crompton MR. (2000). Oncogene 19: 4273-4282.
40. Mossman T. (1983). J Immunol Methods 65: 55-63.
41. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A et al. (1997). Nature 387: 924-929.
42. Nicholson SE, Willson TA, Farley A, Starr R, Zhang JG, Baca M et al. (1999). EMBO J 18: 375-385.
43. Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A et al. (2002). Oncogene 21: 7001-7010.
44. Olayioye MA, Beuvink I, Horsch K, Daly JM, Hynes NE. (1999). J Biol Chem 274: 17209-17218.
45. Qiu H, Miller WT. (2002). J Biol Chem 277: 34634-34641.
46. Qiu H, Miller WT. (2004). Oncogene 23: 2216-2223.
47. Qiu H, Zappacosta F, Su W, Annan RS, Miller WT. (2005). Oncogene 24: 5656-5664.
48. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, Yoshimura A. (2000). J Biol Chem 275: 29338-29347.
49. Serfas MS, Tyner AL. (2003). Oncol Res 13: 409-419.
50. Siyanova EY, Serfas MS, Mazo IA, Tyner AL. (1994). Oncogene 9: 2053-2057.
51. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ et al. (1997). Nature 387: 917-921.
52. Takeda K, Noguchi K, Shi W, Tanaka T, Matsumoto M, Yoshida N et al. (1997). Proc Natl Acad Sci USA 94: 3801-3804.
53. van den Brule FA, Engel J, Stetler-Stevenson WG, Liu FT, Sobel ME, Castronovo V. (1992). Int J Cancer 52: 653-657.
54. Vasioukhin V, Serfas MS, Siyanova EY, Polonskaia M, Costigan VJ, Liu B et al. (1995). Oncogene 10: 349-357.
55. Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J et al. (1995). Science 269: 81-83.